发明名称 ORAL DRUG COMPLIANCE MONITORING USING RADIO FREQUENCY IDENTIFICATION TAGS
摘要 A device useful for oral drug delivery device consisting of: (a) a capsule, tablet or pill designed to disperse in the gastrointestinal system; (b) an RFID tag positioned in the capsule, tablet or pill, the RFID tag comprising an antenna; (c) an object selected from the group consisting of a magnet, a ferromagnetic object, a ferrite object and an electromagnetic shielding object positioned within, over or adjacent the antenna of the RFID tag to alter the antenna characteristics of the RFID tag so that if the RFID tag is interrogated before the capsule, tablet or pill disperses in the gastrointestinal system, the response of the RFID tag is sufficiently altered or attenuated to determine that the capsule, tablet or pill has not dispersed in the gastrointestinal system and so that if the RFID tag is interrogated after the capsule, tablet or pill has dispersed in the gastrointestinal system, the object separates from the RFID tag so that the response of the RFID tag is sufficiently detectable to determine that the capsule, tablet or pill has dispersed in the gastrointestinal system. Alternatively, a switch can be used to signal ingestion of the device, and change the response of the device. In another embodiment, the instant invention is a device useful for oral drug delivery, consisting of: (a) a capsule, tablet or pill designed to disperse in the gastrointestinal system; (b) a first non-anti-collision RFID tag positioned in the capsule; (c) a second non-anti-collision RFID tag positioned in the capsule, so that if the RFID tags are interrogated by an RFID reader before the capsule, tablet or pill disperses in the gastrointestinal system, the response of the RFID tags collide and so that after the dispersible material of the capsule has dispersed in the gastrointestinal system thereby allowing the first and second non-anti-collision tags to separate from each other, then the response of the RFID tags is sufficiently different from each other to determine that the capsule has dispersed in the gastrointestinal system.
申请公布号 WO2006127355(A2) 申请公布日期 2006.11.30
申请号 WO2006US19079 申请日期 2006.05.18
申请人 DOW GLOBAL TECHNOLOGIES INC.;MERCURE, PETER, KIP;JONES, CHRISTOPHER, M.;WARREN, MALCOLM, W.;BABINEC, SUSAN, J.;BERNIUS, MARK, T.;CASTILLO, FLOR, A.;CRANLEY, PAUL, E.;DANOWSKI, KRISTINE, L.;FELIX, MARK, SB;FLETCHER, ROBERT, B.;HALEY, ROBERT, PAUL;KALANTAR, THOMAS, H.;MCDOUGALL, CHRIS, W.;PRESSLER, MICHELLE, A.;ROSNER, BETTINA, M.;SIMON, JAIME;STRAND, DEIDRE, A.;SUN, LARRY;WHITE, DOUGLAS, P. 发明人 MERCURE, PETER, KIP;JONES, CHRISTOPHER, M.;WARREN, MALCOLM, W.;BABINEC, SUSAN, J.;BERNIUS, MARK, T.;CASTILLO, FLOR, A.;CRANLEY, PAUL, E.;DANOWSKI, KRISTINE, L.;FELIX, MARK, SB;FLETCHER, ROBERT, B.;HALEY, ROBERT, PAUL;KALANTAR, THOMAS, H.;MCDOUGALL, CHRIS, W.;PRESSLER, MICHELLE, A.;ROSNER, BETTINA, M.;SIMON, JAIME;STRAND, DEIDRE, A.;SUN, LARRY;WHITE, DOUGLAS, P.
分类号 A61K9/48;A61K9/20;G06K19/077 主分类号 A61K9/48
代理机构 代理人
主权项
地址